Karaborni; Sami

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karaborni; Sami.The latest application filed is for "controlled release granulations of water-soluble active pharmaceutical ingredients".

Company Profile

16.22.41

Karaborni; Sami - Cupertino CA
KARABORNI; Sami - South San Francisco CA
KARABORNI; Sami - San Francisco CA
Karaborni; Sami - Lansdale PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified release compositions of a gamma-hydroxybutyric acid derivative Grant 11,395,801 - Karaborni , et al. July 26, 2	2022-07-26
Controlled Release Granulations Of Water-soluble Active Pharmaceutical Ingredients App 20220183977 - KARABORNI; SAMI ; et al.	2022-06-16
Pharmaceutical granulations of water-soluble active pharmaceutical ingredients Grant 11,357,734 - Karaborni , et al. June 14, 2	2022-06-14
Controlled release granulations of water-soluble active pharmaceutical ingredients Grant 11,304,906 - Karaborni , et al. April 19, 2	2022-04-19
Modified Release Compositions Of A Gamma-hydroxybutyric Acid Derivative App 20220105044 - KARABORNI; SAMI ; et al.	2022-04-07
Pharmaceutical Compositions of Dimethyl Fumarate App 20220105067 - Karaborni; Sami ; et al.	2022-04-07
Pharmaceutical compositions of dimethyl fumarate Grant 11,229,621 - Karaborni , et al. January 25, 2	2022-01-25
Pharmaceutical Granulations Of Water-soluble Active Pharmaceutical Ingredients App 20210393537 - KARABORNI; Sami ; et al.	2021-12-23
Controlled Release Granulations Of Water-soluble Active Pharmaceutical Ingredients App 20210393529 - KARABORNI; SAMI ; et al.	2021-12-23
Pharmaceutical compositions of fumaric acid esters Grant 11,135,296 - Manthati , et al. October 5, 2	2021-10-05
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof App 20210145755 - Karaborni; Sami ; et al.	2021-05-20
Crystalline form of an avibactam derivative Grant 11,008,321 - Karaborni May 18, 2	2021-05-18
Crystalline Forms Of C-c Chemokine Receptor Type 4 Antagonist And Uses Thereof App 20210139487 - ARNOLD; David J. ; et al.	2021-05-13
Corticotropin Releasing Factor Receptor Antagonists App 20210137935 - HOWERTON; Alexis ; et al.	2021-05-13
Solid Forms Of Cerdulatinib App 20210130330 - Pandey; Anjali ; et al.	2021-05-06
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects Grant 10,945,984 - Cundy , et al. March 16, 2	2021-03-16
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof Grant 10,940,117 - Karaborni , et al. March 9, 2	2021-03-09
Solid forms of cerdulatinib Grant 10,865,198 - Pandey , et al. December 15, 2	2020-12-15
Crystalline Form Of An Avibactam Derivative App 20200291022 - Karaborni; Sami	2020-09-17
Corticotropin Releasing Factor Receptor Antagonists App 20200255436 - Kind Code	2020-08-13
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof App 20200246271 - Kind Code	2020-08-06
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof Grant 10,716,760 - Karaborni , et al.	2020-07-21
Pharmaceutical Compositions of Dimethyl Fumarate App 20200155496 - Karaborni; Sami ; et al.	2020-05-21
Pharmaceutical compositions of dimethyl fumarate Grant 10,576,055 - Karaborni , et al.	2020-03-03
Solid Forms Of Cerdulatinib App 20200031804 - Pandey; Anjali ; et al.	2020-01-30
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof App 20200000758 - Virsik; Peter A. ; et al.	2020-01-02
Pharmaceutical Compositions of Dimethyl Fumarate App 20190091196 - Karaborni; Sami ; et al.	2019-03-28
Pharmaceutical compositions of dimethyl fumarate Grant 10,179,118 - Karaborni , et al. Ja	2019-01-15
Pharmaceutical compositions of fumaric acid esters Grant 9,999,672 - Manthati , et al. June 19, 2	2018-06-19
Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use Grant 9,895,336 - Mao , et al. February 20, 2	2018-02-20
Crystalline Forms Of (n, N-diethylcarbamoyl)methyl Methyl (2e)but-2-ene-1,4-dioate, Methods Of Synthesis And Use App 20170368014 - Mao; Chen ; et al.	2017-12-28
Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use Grant 9,795,581 - Mao , et al. October 24, 2	2017-10-24
Crystalline Forms Of (n, N-diethylcarbamoyl)methyl Methyl (2e)but-2-ene-1,4-dioate, Methods Of Synthesis And Use App 20170239206 - Mao; Chen ; et al.	2017-08-24
Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use Grant 9,682,057 - Mao , et al. June 20, 2	2017-06-20
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof App 20170157056 - Karaborni; Sami ; et al.	2017-06-08
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof Grant 9,597,292 - Karaborni , et al. March 21, 2	2017-03-21
Crystalline Forms Of (n,n-diethylcarbamoyl)methyl Methyl (2e)but-2-ene-1,4-dioate, Methods Of Synthesis And Use App 20170042853 - Mao; Chen ; et al.	2017-02-16
Oral Dosage forms having a High Loading of a Gabapentin Prodrug App 20170035714 - Karaborni; Sami ; et al.	2017-02-09
Cocrystals of dimethyl fumarate Grant 9,421,182 - Mao , et al. August 23, 2	2016-08-23
Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use Grant 9,416,096 - Mao , et al. August 16, 2	2016-08-16
Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof App 20160113879 - Karaborni; Sami ; et al.	2016-04-28
Pharmaceutical Compositions Of Fumaric Acid Esters App 20150265707 - Manthati; Suresh Kumar ; et al.	2015-09-24
Nanoparticle Compositions Of Dimethyl Fumarate App 20150079180 - Karaborni; Sami ; et al.	2015-03-19
Crystalline Forms Of (n,n-diethylcarbamoyl)methyl Methyl (2e)but-2-ene-1,4-dioate, Methods Of Synthesis And Use App 20150073049 - Mao; Chen ; et al.	2015-03-12
Cocrystals Of Dimethyl Fumarate App 20140378542 - Mao; Chen ; et al.	2014-12-25
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof App 20140348914 - Karaborni; Sami ; et al.	2014-11-27
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof App 20140348915 - Karaborni; Sami ; et al.	2014-11-27
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects App 20140350018 - Cundy; Kenneth C. ; et al.	2014-11-27
Pharmaceutical Compositions Of Dimethyl Fumarate App 20140284245 - Karaborni; Sami ; et al.	2014-09-25
Levodopa prodrug mesylate hydrate Grant 8,722,733 - Karaborni , et al. May 13, 2	2014-05-13
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof App 20140065211 - Karaborni; Sami ; et al.	2014-03-06
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof App 20140056978 - Karaborni; Sami ; et al.	2014-02-27
Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug App 20140056973 - Ma; Sarina Grace Harris ; et al.	2014-02-27
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects App 20140057917 - Cundy; Kenneth C. ; et al.	2014-02-27
Levodopa Prodrug Mesylate Hydrate App 20130184344 - KARABORNI; SAMI ; et al.	2013-07-18
Levodopa prodrug mesylate hydrate Grant 8,399,513 - Karaborni , et al. March 19, 2	2013-03-19
Oral Dosage Forms Having A High Loading Of A Tranexamic Acid Prodrug App 20110184060 - HARRIS MA; Sarina Grace ; et al.	2011-07-28
Sustained Release Oral Dosage Forms Of An R-baclofen Prodrug App 20100255093 - Edgren; David E. ; et al.	2010-10-07
Oral Dosage Forms Having A High Loading Of A Gabapentin Prodrug App 20100226981 - Karaborni; Sami ; et al.	2010-09-09
Levodopa Prodrug Mesylate Hydrate App 20100099761 - Karaborni; Sami ; et al.	2010-04-22
Mannitol formulation for integrin receptor antagonist App 20060030581 - DeBusi; Laura A. ; et al.	2006-02-09
Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant App 20050165000 - Robertson, Sandra K. ; et al.	2005-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.